When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa

Journal Article

2013

Permanent link to this Item
http://hdl.handle.net/11427/15006
 http://dx.doi.org/10.1371/journal.pmed.1001555
Files
Schomaker_When_to_Start_ART_2013.pdf (601.81 KB)
Authors
Schomaker, Michael
Egger, Matthias
Ndirangu, James
Phiri, Sam
Moultrie, Harry
Technau, Karl
Cox, Vivian
Giddy, Janet
Chimbetete, Cleophas
Wood, Robin
Journal Title

PLOS Medicince

Link to Journal
http://journals.plos.org/plosmedicine
Journal ISSN
Volume Title
Publisher

Public Library of Science

Publisher

University of Cape Town

Department
Institute of Infectious Disease and Molecular Medicine
Faculty
Faculty of Health Sciences
License

http://creativecommons.org/licenses/by/4.0

Series
Abstract
Michael Schomaker and colleagues estimate the mortality associated with starting ART at different CD4 thresholds among children aged 2-5 years using observational data collected in cohort studies in Southern Africa. Please see later in the article for the Editors' Summary
Description
Keywords
Children
Antiretroviral therapy
HIV
AIDS
HIV infections
Death rates
Africa
HIV epidemiology

Reference:

Schomaker, M., Egger, M., Ndirangu, J., Phiri, S., Moultrie, H., Technau, K., ... & Davies, M. A. (2013). When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS medicine, 10(11), e1001555. doi:10.1371/journal.pmed.1001555

Collections
Journal Articles